Table III.
Expression of TGF-β1, IL-10 and IL-12 in the three groups after OLT.
| Groups | n | TGF-β1 | IL-10 | IL-12 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | + | ++ | +++ | – | + | ++ | +++ | – | + | ++ | +++ | |||||
| A | 6 | 2 | 4 | 0 | 0 | 2 | 4 | 0 | 0 | 0 | 1 | 5 | 0 | |||
| B | 6 | 0a | 2 | 4 | 0 | 0 | 0 | 1 | 5 | 1 | 5 | 0 | 0 | |||
| C | 6 | 0 | 0 | 1 | 5 | 0b | 0 | 0 | 6 | 6 | 0 | 0 | 0 | |||
| H | 13.859 | 15.065 | 14.606 | |||||||||||||
| P | 0.001 | 0.001 | 0.001 | |||||||||||||
a
TGF-β1, Group B compared with A, U=4.000, P=0.014
b
IL-10, Group C compared with B, U=15.000, P=0.317; α'=0.05/3. Expression was determined to be negative (–), weak positive (+), medium positive (++) or strong positive (+++). TGF, transforming growth factor; IL, interleukin; OLT, orthotopic liver transplantation.